Indivior Pharmaceuticals, Inc. (INDV) Form 10-Q Quarterly Reports
Indivior Pharmaceuticals, Inc. (INDV) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: INDV
CIK: 1625297
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerAlison Mount
Audit LocationRichmond, Virginia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | FORM 8-K | 0001104659-26-116253 | View SEC Doc Filr Page |
| 425 | 2026-10-06 | — | 425 | 0001104659-26-113885 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-06 | FORM 8-K | 0001104659-26-113883 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-30 | — | SCHEDULE 13G Filing | 0001104659-26-112446 | View SEC Doc Filr Page |
| 425 | 2026-09-17 | — | 425 | 0001104659-26-108418 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-16 | FORM 8-K | 0001104659-26-108417 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-09 | 8-K | 0001625297-26-000028 | View SEC Doc Filr Page |
| EFFECT | 2026-09-11 | — | EFFECT Filing | 9999999995-26-002953 | View SEC Doc Filr Page |
| 424B3 | 2026-09-11 | — | 424B3 | 0001104659-26-107070 | View SEC Doc Filr Page |
| S-4/A | 2026-09-09 | — | S-4/A | 0001104659-26-106390 | View SEC Doc Filr Page |
| S-4 | 2026-08-28 | — | S-4 | 0001104659-26-103278 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-27 | FORM 4 | 0002014440-26-000012 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-13 | — | SCHEDULE 13D/A Filing | 0001140361-26-032874 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-05 | FORM 4 | 0002014440-26-000010 | View SEC Doc Filr Page |
| 425 | 2026-08-04 | — | 425 | 0001193125-26-331036 | View SEC Doc Filr Page |
| 425 | 2026-08-03 | — | 425 | 0001193125-26-330875 | View SEC Doc Filr Page |
| 10-Q | 2026-08-03 | 2026-06-30 | 10-Q | 0001628280-26-051895 | View SEC Doc Filr Page |
| 425 | 2026-08-03 | — | 425 | 0001193125-26-329620 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001193125-26-329618 | View SEC Doc Filr Page |
| 425 | 2026-08-03 | — | 425 | 0001193125-26-329521 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001193125-26-329520 | View SEC Doc Filr Page |
| 425 | 2026-08-03 | — | 425 | 0001193125-26-329517 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-01 | 8-K | 0001193125-26-329513 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-10 | FORM 4 | 0002014639-26-000011 | View SEC Doc Filr Page |
| 144 | 2026-07-10 | — | 144 Filing | 0001959173-26-005188 | View SEC Doc Filr Page |